Exploitation du pétrole et rébellions dans le delta du Niger

Le Nigeria, pays le plus peuplé du continent africain, est en proie à divers conflits depuis plusieurs décennies (guerre du Biafra dans les années 1960, contentieux avec le Cameroun voisin sur le tracé des frontières, tensions entre musulmans et chrétiens à l’intérieur du pays, etc.). Cette carte se propose d’illustrer la « zone grise » que constitue la région du delta du Niger au sud du pays (fig. 1). En effet, cette partie du Nigeria constitue un enjeu stratégique depuis que la Royal Dutch ..

Scleroderma renal crisis in tropical region: two senegalese cases

Scleroderma renal crisis (SRC) is defined as the new onset of accelerated arterial hypertension and /or rapidly progressive oliguric renal failure during the course of systemic sclerosis. It is a rare but life-threatening complication. This formerly serious complication has got a considerable brighter outlook since the introduction of angiotensin converting enzyme inhibitors (ACE) however the mortality is still remaining high. We report two cases of SRC which to our knowledge are the firsts described in Dakar. They were two women aged 45 and 32 years, one of them was previously following for systemic sclerosis. Both of them had malignant hypertension associated with rapidly progressive renal failure, the other was put under corticosteroid therapy four months before SRC occurrence. The histological and laboratory finding showed thrombotic microangiopathy. The height blood pressure returned to normal value after treatment with ACE inhibitors. The final outcome was undesirable with the death of one after two months due to the hemodialysis discontinuation and persistence of renal failure in the other.Keywords: Scleroderma renal crisis, corticosteroids, thrombotic microangiopathy, Daka

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

Scale-up of home-based management of malaria based on rapid diagnostic tests and artemisinin-based combination therapy in a resource-poor country: results in Senegal

<p>Abstract</p> <p>Background</p> <p>Effective case management of malaria requires prompt diagnosis and treatment within 24 hours. Home-based management of malaria (HMM) improves access to treatment for populations with limited access to health facilities. In Senegal, an HMM pilot study in 2008 demonstrated the feasibility of integrated use of RDTs and ACT in remote villages by volunteer Home Care Providers (HCP). Scale-up of the strategy began in 2009, reaching 408 villages in 2009 and 861 villages in 2010. This paper reports the results of the scale-up in the targeted communities and the impact of the strategy on malaria in the formal health sector.</p> <p>Methods</p> <p>Data reported by the HCPs were used to assess their performance in 2009 and 2010, while routine malaria morbidity and mortality data were used to assess the impact of the HMM programme. Two high transmission regions where HMM was not implemented until 2010 were used as a comparison.</p> <p>Results and discussion</p> <p>From July 2009 through May 2010, 12582 suspected cases were managed by HCPs, 93% (11672) of whom were tested with an RDT. Among those tested, 37% (4270) had a positive RDT, 97% (4126) of whom were reported treated and cured. Home care providers referred 6871 patients to health posts for management: 6486 with a negative RDT, 119 infants < 2 months, 105 pregnant women, and 161 severe cases. There were no deaths among these patients. In 2009 compared to 2008, incidence of suspected and confirmed malaria cases, all hospitalizations and malaria-related hospitalizations decreased in both intervention and comparison regions. Incidence of in-hospital deaths due to malaria decreased by 62.5% (95% CI 43.8-81.2) in the intervention regions, while the decrease in comparison regions was smaller and not statistically significant.</p> <p>Conclusion</p> <p>Home-based management of malaria including diagnosis with RDT and treatment based on test results is a promising strategy to improve the access of remote populations to prompt and effective management of uncomplicated malaria and to decrease mortality due to malaria. When scaled-up to serve remote village communities in the regions of Senegal with the highest malaria prevalence, home care providers demonstrated excellent adherence to guidelines, potentially contributing to a decrease in hospital deaths attributed to malaria.</p

Réactivation d’une hépatite B occulte chez un patient drépanocytaire homozygote: cas clinique et revue de la littérature

L'hépatite B occulte correspond à la présence de l'ADN du virus de l'hépatite B dans le sérum et/ou dans le foie d'un patient malgré la négativité de l'AgHBs. C'est une forme clinique habituellement asymptomatique. Sa réactivation est rare et survient en général chez le sujet immunodéprimé. Nous rapportons un cas d'un patient sénégalais de 21 ans, drépanocytaire homozygote, qui présentait un ictère de type cholestatique chez qui l'exploration biologique concluait a une réactivation d'une hépatite B occulte. Cette observation souligne la nécessité de rechercher systématiquement une réactivation d'une hépatite B occulte devant toute hépatopathie aigue chez le drépanocytaire

Asthme aigu grave de l’enfant : caractéristiques épidémiologiques, cliniques, thérapeutiques et évolutifs au Sénégal : Severe acute asthma of the child: epidemiological, clinical, therapeutic and evolutive characteristics in Senegal

Context and objective. The lethality of asthma is related to the occurrence of severe acute asthma which is a crisis that does not yield under initial bronchodilator therapy. The objective of this study was to describe the epidemiological, diagnostic, therapeutic and evolutionary characteristics of children hospitalized for a severe acute asthma attack. Methods. We conducted a retrospective study of 11 years (from January 1st, 2005 and December 31st, 2015) at the Pediatric Emergency and Respiratory Department of the Albert Royer Children's Hospital (CHNEAR). 89 Children aged 0 to 15 years hospitalized for severe asthma or severe acute asthma were included. Results. The hospital prevalence of severe asthma attacks was 0.18%. The average age of the children was 44.21 months and the sex ratio was 1.69. The hospitalizations peaks have been registered during the months of July and December. 6.6% of patients were undergoing treatment and 17.9% had already been hospitalized for severe asthma attacks. The main biological abnormalities were: hypoxemia (79.7%), anemia (66.29%) and leukocytosis (44.9%). Radiological abnormalities were dominated by pulmonary over distension (60.7%) and bronchial syndrome (36%). All patients were under oxygen, salbutamol and corticosteroids. One death was encountered. The average hospital length of stay was 3.75 days. The complications were pneumo-mediastinum / cervico-mediastinal emphysema in 4 cases, pneumothorax in 2 cases and atelectasis in 1 case. Conclusion. Severe acute asthma is a relatively rare condition, but it is always associated with a significant morbidity. Contexte et objectif. La létalité de l’asthme est liée à la survenue d’asthme aigu grave qui est une crise qui ne cède pas sous traitement bronchodilatateur initial. L’objectif de cette étude était de décrire les caractéristiques épidémiologiques, diagnostiques, thérapeutiques et évolutives des enfants hospitalisés pour une crise d’asthme aigu grave.&nbsp;Méthodes. Nous avons conduit une étude documentaire portant sur une période de 11 ans (1 janvier 2005-31 décembre 2015) et réalisée aux services des urgences pédiatriques et de pneumologie du centre hospitalier national d’enfants Albert Royer (CHNEAR). Etaient inclus, 89 enfants de 0 à 15ans hospitalisés pour crise d’asthme sévère ou asthme aigu grave.&nbsp;Résultats. La prévalence hospitalière des crises d’asthmes sévère était de 0,18%. Leur âge moyen était de 44,2 mois et le sexe ratio 1,6. Les pics d’hospitalisations ont été enregistrés durant les mois de Juillet et Décembre. 6,6% des patients étaient sous traitement de fond et 17,9% avaient déjà été hospitalisés pour crises d’asthmes sévères. L’hypoxémie (79,7%), l’anémie (66,2%) et l’hyperleucocytose (44,9%) étaient les principales anomalies biologiques. Les signes radiologiques étaient dominés par l’hyperinflation pulmonaire (60,7%) et le syndrome bronchique (36%). Tous les patients étaient ont bénéficié de l’oxygène, le salbutamol et les corticoïdes. Sous cette attitude thérapeutique, un décès avait été déploré. La durée moyenne de l’hospitalisation était de 3,75 jours. Les complications enregistrées étaient le pneumo-médiastin/emphysème cervico-médiastinal dans 4 cas, le pneumothorax dans 2 cas, la rupture trachéale dans 1 cas et l’atélectasie dans 1 cas.&nbsp;Conclusion. L’asthme aigu grave semble peu fréquent mais reste toujours associée à une morbidité non négligeable

Univariate and multivariate risk factors analysis according to "symptomatic/asymptomatic" status for Period 2 (from June 26 to October 31^st, 2020).

(DOCX)</p

Spatial distribution of COVID-19 positive cases at district level.

Spatial distribution of COVID-19 positive cases at district level.</p

Epidemiological parameters comparison according to different periods.

Epidemiological parameters comparison according to different periods.</p